Form 8-K - Current report:
SEC Accession No. 0001193125-15-097744
Filing Date
2015-03-19
Accepted
2015-03-19 08:16:08
Documents
16
Period of Report
2015-03-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d894174d8k.htm 8-K 14683
2 EX-99.1 d894174dex991.htm EX-99.1 14695
3 EX-99.2 d894174dex992.htm EX-99.2 8625
4 GRAPHIC g8941741.jpg GRAPHIC 55056
5 GRAPHIC g89417410.jpg GRAPHIC 115460
6 GRAPHIC g89417411.jpg GRAPHIC 84693
7 GRAPHIC g89417412.jpg GRAPHIC 103415
8 GRAPHIC g8941742.jpg GRAPHIC 137127
9 GRAPHIC g8941743.jpg GRAPHIC 61171
10 GRAPHIC g8941744.jpg GRAPHIC 68428
11 GRAPHIC g8941745.jpg GRAPHIC 97327
12 GRAPHIC g8941746.jpg GRAPHIC 85972
13 GRAPHIC g8941747.jpg GRAPHIC 91772
14 GRAPHIC g8941748.jpg GRAPHIC 96263
15 GRAPHIC g8941749.jpg GRAPHIC 95706
16 GRAPHIC g894174img1.jpg GRAPHIC 12210
  Complete submission text file 0001193125-15-097744.txt   1563027
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 15711634
SIC: 2834 Pharmaceutical Preparations